The platform's expanded security options help ensure only designated, approved hospital staff access clinical data transmitted between the devices and hospital information technology systems as part of the intravenous (I.V.) medication administration process. This can help health care providers more readily comply with patient confidentiality regulations, such as the Health Insurance Portability and Accountability Act, or HIPAA, in securing patient data against inadvertent release.
"Hospira is pleased to be the first to offer hospitals advanced security options and multi-mode flexibility, allowing them to optimize their wireless communications", stated Symeria Hudson, vice president, Marketed Products, Global Devices. "By helping ensure secure, unimpeded data exchange, Hospira's new offering will help hospitals improve the efficiency of their information technology infrastructure today, while reducing the need for future upgrades."
Most wireless products - such as mobile phones, pagers and other medical devices - communicate via the 802.11 "b" or "g" modes on the 2.4 GHz band. With Hospira's new platform, hospitals can choose to operate the company's infusion devices in the "b" or "g" modes, as well as the less frequently used "a" (5 GHz band) wireless mode, to help ensure clear, consistent data transmission.
"At Virtua Health, wireless technologies play a key role in communicating patient and clinical data in real-time", stated John Bloomer, chief information officer, Virtua Health. "Our hospital is committed to providing an outstanding patient experience, and we are pleased that Hospira's new offering will provide a safe and timely conduit for information, meeting leading encryption and authentication standards."
Hospira is currently offering this new capability with the Plum A+ single-channel infusion device and will be adding it to its Plum A+3 triple-channel device, LifeCare PCA patient-controlled analgesia system and Symbiq infusion system later this year. The devices work in conjunction with the Hospira MedNet system, a scaleable and upgradeable patient safety platform. More than 400.000 Hospira infusion pumps are installed in hospitals worldwide today.
Hospira Inc. is a global speciality pharmaceutical and medication delivery company dedicated to Advancing Wellness by developing, manufacturing and marketing products that help improve the productivity, safety and efficacy of patient care. In February 2007, Hospira acquired Mayne Pharma Limited to become the world leader in speciality generic injectable pharmaceuticals. With 70 years of service to the hospital industry, Hospira's portfolio includes one of the industry's broadest lines of generic acute-care and oncology injectables, which help address the high cost of proprietary pharmaceuticals; and integrated solutions for medication management and infusion therapy. Headquartered north of Chicago in Lake Forest, Illinois, Hospira has approximately 15.000 employees and 18 manufacturing facilities worldwide.